A method for modulating at least one pharmacokinetic property of a protease inhibitor upon administration to a host is provided. One administers to the host an effective amount of a bifunctional compound of less than about 5000 daltons comprising the protease inhibitor or an active derivative thereof and a pharmacokinetic modulating moiety. The pharmacokinetic modulating moiety binds to at least one intracellular protein. The bifunctional compound has at least one modulated pharmacokinetic property upon administration to the host as compared to a free drug control that comprises the protease inhibitor.
提供了一种在给宿主施用蛋白酶抑制剂时调节至少一种药代动力学特性的方法。向宿主施用不超过约5000道尔顿的双功能化合物的有效量,该化合物包括蛋白酶抑制剂或其活性衍
生物和药代动力学调节基团。药代动力学调节基团结合至少一个细胞内蛋白质。与包含蛋白酶抑制剂的自由药物对照相比,双功能化合物在向宿主施用后具有至少一个调节的药代动力学特性。